Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
17
×
life sciences
national blog main
boston blog main
clinical trials
national top stories
boston top stories
san francisco blog main
amgen
new york top stories
fda
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
eli lilly
national
san francisco top stories
startups
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
novartis
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
cancer
deals
drugs
alirocumab
bristol-myers squibb
What
drug
17
×
new
17
×
medicines
fda
approval
biotech
drugs
migraine
won
bio
cholesterol
class
companies
lead
million
ready
year
approved
brings
cancer
chief
company
decades
developed
earlier
eli
friday
gets
ipo
lilly
liquid
lowering
medco
officer
oral
pain
patients
raised
raises
research
Language
unset
Current search:
biotech
×
drug
×
new
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
@techcrunch.com
6 years ago
Biomedical startup AesculaTech is creating a new, more patient-friendly drug delivery system
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks